Electronic submissions in compliance with regulatory requirements for the global pharmaceutical industry
by Kyberpass Corp.
This white paper by Kyberpass Corp. describes the technology behind end-to-end electronic submission of new drug applications. Document management systems, often already deployed in a life sciences company, are integrated with the tools needed for authentication, authorization and accounting, and all of these applications are tightly integrated with an appropriate underlying trust infrastructure. The paper also offers some options for electronic submission tools, including Adobe Self-Sign Capability, Livelink and Kyberpass TrustPlatform.
| Published: | 2004 |
| Format: | |
| Length: | 5 pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
